Riskpilot← Back to searchSign inGet full accessDuoCort Pharma AB
ABDissolvedOrg 5567344006Other research and experimental development on natural sciences and engineering · NACE 7219Est. 20070 employees
Revenue 2021
SEK 13,7M
-19% vs 2020
EBITDA margin
651.8%
+377% vs 2020
Equity ratio
90.0%
Financial strength
Net profit 2021
SEK 66,1M
+608% vs 2020
| Revenue | SEK 13,7M | -19% |
| EBITDA | SEK 89,3M | +377% |
| Net profit | SEK 66,1M | +608% |
| Total assets | SEK 178,9M | +87% |
| Equity | SEK 161,1M | +70% |
| Employees | 0 | — |
Legal name
DuoCort Pharma AB
Org number
5567344006
Legal form
Aktiebolag
NACE code
7219 · Other research and experimental development on natural sciences and engineering
Founded
6 juli 2007
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva forskning, utveckling, utbildning, marknadsföring och försäljning inom det medicinska området samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | 11 480 | 17 380 | 16 796 | 16 968 | 13 702 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 6 733 | 10 613 | 11 259 | 17 771 | 18 025 | 18 719 | 89 303 |
| Depreciation & amort. | −8 067 | −8 067 | −8 067 | −8 067 | −8 067 | −8 067 | −6 055 |
| EBIT | −1 334 | 2 546 | 3 192 | 9 704 | 9 958 | 10 652 | 83 248 |
| Net financials | — | — | — | — | — | −643 | 45 |
| Profit before tax | −1 334 | 2 546 | 3 192 | 9 704 | 9 958 | 10 009 | 83 293 |
| Tax | −0 | −0 | −0 | −0 | −0 | −666 | −17 158 |
| Net profit | −1 334 | 2 546 | 3 192 | 9 704 | 9 958 | 9 343 | 66 135 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Total assets | 67 142 | 69 688 | 73 032 | 82 662 | 92 542 | 95 651 | 178 944 |
| Equity | 60 242 | 62 788 | 65 980 | 75 684 | 85 642 | 94 985 | 161 120 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 900 | 6 900 | 7 052 | 6 978 | 6 900 | 666 | 17 824 |
| Total debt | 6 900 | 6 900 | 7 052 | 6 978 | 6 900 | 666 | 17 824 |
EBITDA margin
651.8%
This company
15.8%
Market median
+4025% vs market
20152021
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
20152021
Return on equity
41.0%
This company
18.4%
Market median
+123% vs market
20152021
Net profit margin
482.7%
This company
8.1%
Market median
+5859% vs market
20152021
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20152021
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20152021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AJ Chief Auditor | Chief Auditor | 2022 | — | — |
RH Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DuoCort Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Joakim Toivo Taaler | Chief Auditor | 0 companies |
| Resul Hamurcu | Chief Auditor | 0 companies |
| Jacob Fredrik Westin | Board of Directors | 0 companies |
| Sofia Therese Hultman | Board of Directors | 0 companies |
| Vatroslav Mateljic | Chairman | 0 companies |